Anhui Jiliu Blockchain Technology Co., Ltd – Trademark Portfolio

Entity Type: 99

Anhui Jiliu Blockchain Technology Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ALEPHIUM. The owner is based in Hefei.

Room 611-73, 3333 Xiyou Road

Gaoxin District

Hefei 230001 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ALEPHIUM
ALEPHIUM
Registered 2019

Trademark Classifications

Anhui Jiliu Blockchain Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Anhui Jiliu Blockchain Technology Co., Ltd have?

Anhui Jiliu Blockchain Technology Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Anhui Jiliu Blockchain Technology Co., Ltd file in?

Anhui Jiliu Blockchain Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Anhui Jiliu Blockchain Technology Co., Ltd's most well-known trademarks?

Anhui Jiliu Blockchain Technology Co., Ltd's registered trademark portfolio includes well-known marks such as ALEPHIUM. These are among 1 currently registered trademark in the portfolio.

What is Anhui Jiliu Blockchain Technology Co., Ltd's trademark registration success rate?

Anhui Jiliu Blockchain Technology Co., Ltd has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.